全文获取类型
收费全文 | 506篇 |
免费 | 29篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 41篇 |
妇产科学 | 8篇 |
基础医学 | 61篇 |
口腔科学 | 4篇 |
临床医学 | 53篇 |
内科学 | 154篇 |
皮肤病学 | 4篇 |
神经病学 | 36篇 |
外科学 | 19篇 |
综合类 | 8篇 |
预防医学 | 63篇 |
眼科学 | 1篇 |
药学 | 49篇 |
中国医学 | 1篇 |
肿瘤学 | 31篇 |
出版年
2023年 | 4篇 |
2022年 | 3篇 |
2021年 | 5篇 |
2020年 | 10篇 |
2019年 | 13篇 |
2018年 | 11篇 |
2017年 | 10篇 |
2016年 | 8篇 |
2015年 | 7篇 |
2014年 | 14篇 |
2013年 | 14篇 |
2012年 | 23篇 |
2011年 | 26篇 |
2010年 | 11篇 |
2009年 | 12篇 |
2008年 | 20篇 |
2007年 | 15篇 |
2006年 | 20篇 |
2005年 | 21篇 |
2004年 | 22篇 |
2003年 | 19篇 |
2002年 | 27篇 |
2001年 | 15篇 |
2000年 | 15篇 |
1999年 | 12篇 |
1998年 | 10篇 |
1997年 | 9篇 |
1996年 | 10篇 |
1995年 | 10篇 |
1994年 | 7篇 |
1993年 | 6篇 |
1992年 | 15篇 |
1991年 | 11篇 |
1990年 | 11篇 |
1989年 | 7篇 |
1988年 | 7篇 |
1987年 | 6篇 |
1986年 | 5篇 |
1985年 | 4篇 |
1983年 | 5篇 |
1982年 | 6篇 |
1980年 | 4篇 |
1979年 | 5篇 |
1975年 | 5篇 |
1974年 | 4篇 |
1973年 | 3篇 |
1972年 | 8篇 |
1971年 | 4篇 |
1967年 | 3篇 |
1966年 | 2篇 |
排序方式: 共有536条查询结果,搜索用时 15 毫秒
1.
2.
This paper presents a method of improving the TLD-100 dose reassessment performance. This method consists of applying numerical analysis techniques for evaluating the TLD-100 phototransferred thermoluminescence (PTTL) glow curve. From this analysis, a simple procedure for estimating the ultraviolet background components usually present in phototransferred thermoluminescence (TL) signals has been established. This procedure has been implemented in a computer program which performs the automatic evaluation of the glow curves and extracts the dose information contained in the PTTL curves. The use of this computer-aided evaluational method has enabled the extension of the working range of estimated absorbed dose down to 0.2-0.5 mGy with very adequate operational quality for doses even below the conventionally admitted lower reestimation limit (approximately 2 mGy). Because TL readout is a destructive process, the ability to reestimate doses can be important in any kind of dosimetric activity, such as operational dosimetry programs. The other commonly used dosimeter, film, uses a nondestructive readout and, therefore, presents some advantages over TLD when dose reassessment is necessary. With the reported improvements in the TLD-100 dose reassessment performance, the full range of absorbed doses covered by film dosimetry can now be reliably reassessed using TLD-100 dosimeters. 相似文献
3.
P. Phillips S. Shafran G. Garber C. Rotstein F. Smaill I. Fong I. Salit M. Miller K. Williams J. M. Conly J. Singer S. Ioannou 《European journal of clinical microbiology & infectious diseases》1997,16(5):337-345
A randomized trial was conducted to compare the efficacy and safety of fluconazole versus that of amphotericin B in the treatment of candidemia in non-neutropenic adults. Enrollment was stratified by disease severity (APACHE II score). Patients were randomized (1:1) to receive amphotericin B 0.6 mg/kg/day (cumulative dose 8 mg/kg) or fluconazole 800 mg intravenous loading dose, then 400 mg daily for four weeks (intravenous for at least 10 days). Patients were monitored for six months. A total of 106 patients were enrolled. A protocol amendment implemented midway through the trial required patients to be removed from the study and treated with amphotericin B if species identification indicated candidemia due toCandida glabrata orCandida krusei. Baseline characteristics were similar for the two groups; 103 patients (fluconazole, 50; amphotericin B, 53) met the major enrollment criteria. The intention-to-treat analysis indicated successful therapy in 50% of fluconazole recipients compared to 58% of the amphotericin B group (p=0.39; one-sided 95% Cl, –8 to 24%). The efficacy analysis included 84 patients (fluconazole, 42; amphotericin B, 42); successful outcomes were observed in 57% and 62% of cases in the fluconazole and amphotericin B groups, respectively (p=0.66: one-sided 95% Cl, –12 to 22%). The mortality at day 14 for the fluconazole group was 26% and for the amphotericin B group 21% (p=0.52; chi-square test) and remained similar throughout the course of follow-up. Drug-related adverse events were more frequent with amphotericin B than with fluconazole and prompted switching of therapy for two (4%) and zero cases, respectively. Fluconazole and amphotericin B were associated with similar clinical response rates and survival in the treatment of candidemia among non-neutropenic patients; however, drug-related adverse events were more frequent with amphotericin B. 相似文献
4.
5.
Mechanisms of peptide YY release induced by an intraduodenal meal in rats: neural regulation by proximal gut 总被引:5,自引:0,他引:5
Fu-Cheng Xiaomei Anini Younes Chariot Jacques Castex Nathalie Galmiche Jean-Paul Rozé C. 《Pflügers Archiv : European journal of physiology》1997,433(5):571-579
Peptide YY (PYY) release in anaesthetized rats was studied during the 2 h following the intraduodenal administration of a
semi-liquid meal of 21 kJ. Surgical and pharmacological manipulations were performed in order to analyse the mechanisms of
PYY release. Postprandial PYY release was suppressed or strongly decreased by caecocolonectomy, truncal vagotomy, tetrodotoxin,
hexamethonium, sensory denervation by perivagal capsaicin, and by the NO-synthase inhibitor L-N-arginine methyl ester, while atropine, adrenergic blockers, antagonists of type-A or type-B cholecystokinin (CCK) receptors
or bombesin receptors had no effect. Comparing the digestive transit of the semi-liquid meal with the amount of PYY contained
in the small bowel wall showed that nutrients had not reached the area rich in cells containing PYY by 30 min, the time at
which there was a large PYY release in plasma. By 120 min, the meal front had travelled 72% of the small intestine length,
just beginning to reach the PYY-rich part of the ileum. We conclude that the main postprandial PYY release studied in this
model comes from ileal and colonic L-cells indirectly stimulated through a neural mechanism originating in the proximal gut
and involving sensory vagal fibres, nicotinic synapses and NO release, while CCK and bombesin do not seem to be physiologically
involved.
Received: 17 July 1996 / Received after revision: 11 October 1996 / Accepted: 18 October 1996 相似文献
6.
7.
8.
Jean-Michel Liet Soizic Paranon Louis Baraton Jean-Marc Dejode Jean-Christophe Rozé 《Pediatric critical care medicine》2006,7(6):541-544
OBJECTIVE: An adult trial reported the efficacy of recombinant human erythropoietin in critically ill patients with a 19% decrease in red blood cell transfusion. Our aim was to evaluate the relevance of this prophylactic treatment in children hospitalized in a pediatric intensive care unit (PICU). DESIGN: Cohort study from January 1995 to December 2004. SETTING: University hospital PICU. PATIENTS: Children between 1 month and 18 yrs of age. INTERVENTIONS: We searched through a prospective databank for all children hospitalized in the PICU for > or =4 days (potential recipients of erythropoietin, as proposed in the adult trial) and transfused with red blood cells after day 7 following PICU entry (in whom erythropoietin might prevent anemia, according to results of the adult trial). MEASUREMENTS AND MAIN RESULTS: We found that 799 of 2,578 children (31%) were hospitalized for > or =4 days. The study group comprised 787 patients who were hospitalized for > or =4 days in the PICU and for whom full records were available. One hundred eighty-three children in this study group were transfused during their stay in the PICU (median age, 7 months; weight, 6.60 kg). Hemoglobin levels before transfusion (mean +/- sd) were 7.7 +/- 1.5 g/dL. These transfused children represented 23% of the study group and 7% of the total PICU admissions. Forty-seven children (6% of the study group, 2% of the total PICU admissions) were transfused with red blood cells after 7 days of hospitalization and could have benefited from a prophylactic treatment with erythropoietin. Relative risk to benefit of a prophylactic treatment by erythropoietin was higher in cases of mechanical ventilation (relative risk, 1.18) and inotropic treatment (relative risk, 1.72) and if the main diagnosis involved dermatological (relative risk, 3.03) or oncologic disease (relative risk, 3.94). CONCLUSIONS: If we applied the results of the adult trial to our PICU, we would have to treat 31% of the children with prophylactic erythropoietin and thereby expect a reduction of one red blood cell transfusion for every 17 treated patients. 相似文献
9.
Sophie D. Bennett Pim Cuijpers David Daniel Ebert Mhairi McKenzie Smith Anna E. Coughtrey Isobel Heyman Grazia Manzotti Roz Shafran 《Journal of child psychology and psychiatry, and allied disciplines》2019,60(8):828-847
Mental health problems are common in children and adolescents, yet evidence-based treatments are hard to access. Self-help interventions can increase such access. The aim of this paper was to conduct a systematic review and meta-analysis of the use of guided and unguided self-help for children and young people with symptoms of common mental health disorders. In contrast to previous reviews of self-help in children, all types of self-help and multiple mental health disorders were investigated in order to increase power to investigate potential moderators of efficacy. Importantly, studies with control arms as well as those comparing against traditional face-to-face treatments were included. Fifty studies (n = 3396 participants in self-help/guided self-help conditions) met the inclusion criteria. Results demonstrated a moderate positive effect size for guided and unguided self-help interventions when compared against a control group (n = 44; g = 0.49; 95% CI: 0.37 to 0.61, p < .01) and a small but significant negative effect size when compared to other therapies (n = 15; g = −0.17; 95% CI: –0.27 to –0.07, p < .01). Few potential moderators had a significant effect on outcome. Most comparisons resulted in significant heterogeneity and therefore results are interpreted with caution. 相似文献
10.